PT
This startup develops pharmaceutical-grade DMT-based medicines and therapies aimed at treating severe mental illnesses through a tailored psychological treatment model. Utilizing a proprietary extraction technique, the company ensures the standardization of active ingredients at pharmaceutical purity levels, enhancing patient quality of life.
Updated 3 months ago
Funding
$4.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- This startup develops pharmaceutical-grade DMT-based medicines and therapies aimed at treating severe mental illnesses through a tailored psychological treatment model. Utilizing a proprietary extraction technique, the company ensures the standardization of active ingredients at pharmaceutical purity levels, enhancing patient quality of life.